Risk Factors for Recurrence after Resection of Hepatitis C Virus-related Hepatocellular Carcinoma

被引:0
|
作者
Shoji Kubo
Kazuhiro Hirohashi
Hiromu Tanaka
Tadashi Tsukamoto
Taichi Shuto
Takashi Ikebe
Takatsugu Yamamoto
Kenichi Wakasa
Shuhei Nishiguchi
Tetsuo Kuroki
Hiroaki Kinoshita
机构
[1] Second Department of Surgery,
[2] Osaka City University Medical School,undefined
[3] 1-4-3 Asahimachi,undefined
[4] Abeno-ku,undefined
[5] Osaka 545-8585,undefined
[6] Japan,undefined
[7] Second Department of Pathology,undefined
[8] Osaka City University Medical School,undefined
[9] 1-4-3 Asahimachi,undefined
[10] Abeno-ku,undefined
[11] Osaka 545-8585,undefined
[12] Japan,undefined
[13] Department of Pathology,undefined
[14] Osaka City University Hospital,undefined
[15] 1-5-3 Asahimachi,undefined
[16] Abeno-ku,undefined
[17] Osaka 545-8586,undefined
[18] Japan,undefined
[19] Third Department of Internal Medicine,undefined
[20] Osaka City University Medical School,undefined
[21] 1-4-3 Asahimachi,undefined
[22] Abeno-ku,undefined
[23] Osaka 545-8585,undefined
[24] Japan,undefined
来源
World Journal of Surgery | 2000年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although there have been many studies of the risk factors for recurrence after resection of hepatocellular carcinoma (HCC), the subjects were patients with various viral status in the previous studies, and hepatitis C viremia has not been evaluated. We investigated risk factors, including hepatic C viremia and histologic findings of noncancerous hepatic tissue, for recurrence after resection of hepatitis C virus (HCV)-related HCC. A total of 223 patients who underwent liver resection for HCV-related HCC were studied. HCV viremia, laboratory data, degree of HCC malignancy, histologic findings in noncancerous hepatic tissue, preoperative interferon therapy, and operative methods were evaluated for recurrence risk by univariate and multivariate analyses. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin, and the proportion of patients with a high histologic activity score (mild to severe active hepatitis) were significantly higher in patients with HCV viremia than in those without viremia. Serum albumin was significantly lower in patients with HCV viremia. By univariate analysis, older age (> 65 years old), HCV viremia, elevated AST (> 40 IU/L) and ALT (> 45 IU/L), large tumors (> 40 mm), multiple HCCs, moderately or poorly differentiated HCC, portal invasion, mild to severe active hepatitis, and lack of preoperative interferon therapy were risk factors for recurrence. Multivariate analysis showed that older age, HCV viremia, high AST, multiple HCCs, and portal invasion were independent risk factors. For HCV-related HCCs, not only the degree of maliganacy of the HCC but also HCV viremia and active hepatitis are risk factors for recurrence.
引用
收藏
页码:1559 / 1565
页数:6
相关论文
共 50 条
  • [41] Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection
    Young, Shih-Hao
    Chau, Gar-Yang
    Lee, I-Cheng
    Yeh, Yi-Chen
    Chao, Yee
    Huo, Teh-Ia
    Su, Chien-Wei
    Lin, Han-Chieh
    Hou, Ming-Chih
    Lee, Mei-Hsuan
    Huang, Yi-Hsiang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 218 - 229
  • [42] Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma
    Nishiguchi, S
    Tamori, A
    Kubo, S
    INTERVIROLOGY, 2005, 48 (01) : 71 - 75
  • [43] Effects of postoperative interferon-α on recurrence after curative resection in patients with hepatitis C virus-related hepatocellular carcinoma:: A prospective randamizrd trial.
    Nishiguchi, S
    Kubo, S
    Hirohashi, K
    Shuto, T
    Yamazaki, O
    Oka, H
    Igawa, S
    Tamori, A
    Kuroki, T
    Kinoshita, H
    HEPATOLOGY, 1999, 30 (04) : 212A - 212A
  • [44] Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Reply
    Wu, Chun-Ying
    Hsu, Yao-Chun
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 766 - 767
  • [45] Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence
    Liu, Yuanyuan
    Veeraraghavan, Vaishnavi
    Pinkerton, Monica
    Fu, Jianjun
    Douglas, Mark W.
    George, Jacob
    Tu, Thomas
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [46] Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status
    Koda, Masaki
    Tanaka, Shogo
    Takemura, Shigekazu
    Shinkawa, Hiroji
    Kinoshita, Masahiko
    Hamano, Genya
    Ito, Tokuji
    Kawada, Norifumi
    Shibata, Toshihiko
    Kubo, Shoji
    LIVER CANCER, 2018, 7 (03) : 261 - 276
  • [47] Prognosis of Patients with Non-hepatitis B virus-, Non-hepatitis C virus-related Hepatocellular Carcinoma: A Comparison with Hepatitis C virus-related Hepatocellular Carcinoma Patients
    Noda, Yu
    Kawaguchi, Takumi
    Nakano, Masahito
    Niizeki, Takashi
    Kuromatsu, Ryoko
    Koga, Hironori
    Torimura, Takuji
    HEPATOLOGY, 2017, 66 : 765A - 765A
  • [48] Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy
    Yamashita, Yo-ichi
    Shirabe, Ken
    Toshima, Takeo
    Tsuijita, Eiji
    Takeishi, Kazuki
    Harimoto, Norifumi
    Ikegami, Toru
    Yoshizumi, Tomoharu
    Ikeda, Tetsuo
    Soejima, Yuji
    Maehara, Yoshihiko
    HEPATOLOGY RESEARCH, 2013, 43 (12) : 1313 - 1320
  • [49] Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis
    Masuzaki, Ryota
    Yoshida, Haruhiko
    Omata, Masao
    ONCOLOGY, 2010, 78 : 17 - 23
  • [50] Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C
    Yutaka Yamanaka
    Katsuya Shiraki
    Kazumi Miyashita
    Tomoko Inoue
    Tomoyuki Kawakita
    Yumi Yamaguchi
    Yukiko Saitou
    Norihiko Yamamoto
    Takeshi Nakano
    Atsuhiro Nakatsuka
    Koichiro Yamakado
    Kan Takeda
    World Journal of Gastroenterology, 2005, (14) : 2174 - 2178